Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia
References
- 1. REEFMAN E, KUİPER H, JONKMAN MF,. Rheumatology. 2006;:538-44.
- 2. SARZİ-PUTTİNİ P, ATZENİ F, CAPSONİ F,. Autoimmunity. 2005;:507-18.
- 3. MARZANO AV, VEZZOLİ P, CROSTİ C.. Lupus. 2009;:935-40.
- 4. KATZ U, ZANDMAN-GODDARD G.Autoimmun Rev. 2010;:46-50.
- 5. KİNDEM S, LLOMBART B, REQUENA C,. J Dermatol. 2013;:75-6.
- 6. FERNANDES NF, ROSENBACH M, ELENİTSAS R, KİST JM.Arch Dermatol. 2009;:340-1.
- 7. KO JH, HSİEH CI, CHOU CY, WANG KH.. J Dermatol. 2013;:939-40.
- 8. WEGER W, KRÄNKE B, GERGER A,.. J Am Acad Dermatol. 2008;:4-6.
- 9. FLORİSTAN U, FELTES RA, SENDAGORTA E,. Clin Exp Dermatol. 2009;:328-9.
- 10. WİESENTHAL A, MATHERNE R, GİBSON B.. J Drugs Dermatol. 2012;:769-71.
- 11. MERLİN F, PROCHİLO T, KİLDANİ B,. Int J Colorectal Dis. 2008;:715-6.
- 12. VİHİNEN P, PAİJA O, KİVİSAARİ A,: a case report. J Med Case Rep. 2011;:243.
- 13. DUDLEY K, MİCETİCH K, MASSA MC.. Cutis. 1987;:64-6.
- 14. KLUGER N, BESSİS D, GUİLLOT B.. J Dermatolog Treat. 2006;:51-3.
- 15. MOAZZAM N, MALİK AA, MEHDİ SA, POTTİ A.. J Clin Oncol. 2002;:3032-4.
- 16. YOSHİMASU T, HİROİ A, UEDE K, FURUKAWA F.. Eur J Dermatol. 2001;:54-7.
- 17. ALMAGRO BM, STEYLS MC, NAVARRO NL,. J Clin Oncol. 2011;:613-5.
DOI: https://doi.org/10.1515/rjim-2015-0037 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Language: English, Romanian
Page range: 282 - 285
Submitted on: May 1, 2015
Published on: Oct 14, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Related subjects:
© 2015 Ersin Ozaslan, Eray Eroglu, Kevser Gok, Soner Senel, Suleyman Baldane, Lutfi Akyol, Metin Ozkan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution 4.0 License.